Back to Search

Blood RNA Testing for Long COVID Diagnosis

Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19

Recruiting N/A Interventional Study
Long COVID
More trials: COVID-19 clinical trials· COVID-19 trials in Tennessee
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
224 (estimated)
Sponsor
MaxWell Clinic, PLC · Industry
Who this trial is looking for

This trial is looking for people who have long-lasting symptoms after a COVID-19 infection. If you join, you will provide blood samples to help researchers find new ways to diagnose long COVID.

Are You a Good Fit for This Trial?

You may be able to join if

  • I can understand and agree to take part in the study.
  • I have a confirmed COVID-19 diagnosis.
  • I have new, ongoing symptoms after my COVID-19 infection.
  • I am at least 18 years old.

You may not be able to join if

  • I cannot provide my consent for the study.
  • My ongoing health problems are not related to COVID-19.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of specific blood RNA from patients with long COVID together and separately from the apparent health normal controls and other medical conditions that share the signs and symptoms of long COVID.

Trial Locations

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Mentally capable of understanding and completing informed consent for the study. * Precipitants with a lab verified diagnosis of SARS-CoV-2 or clinician note/record that an appropriate rapid test for SARS-CoV-2 was positive. * To qualify for long COVID group participants will …
Contacts

No contact information available.

NCT ID: NCT06311435 Source: ClinicalTrials.gov